Butyrate modulates gene and protein expression in human intestinal endothelial cells

被引:62
作者
Ogawa, H
Rafiee, P
Fisher, PJ
Johnson, NA
Otterson, MF
Binion, DG [1 ]
机构
[1] Med Coll Wisconsin, Froedtert Mem Lutheran Hosp, Vet Adm Med Ctr,Dept MEd, Digest Dis Ctr,Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Froedtert Mem Lutheran Hosp, Vet Adm Med Ctr,Free Rad Res Ctr,Dept Surg, Digest Dis Ctr,Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA
关键词
human intestinal microvascular endothelial cells; sodium butyrate; lipopolysaccharide; ICAM-1; IL-6; cyclooxygenase; 2; prostaglandin E2; nuclear factor-kappa B;
D O I
10.1016/j.bbrc.2003.08.026
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We hypothesized that sodium butyrate, a product of enteric bacterial fermentation, modulates gene expression in gut microvascular endothelium which plays a central role in mucosal immunity. We examined sodium butyrate's effect on LPS-induced gene and protein expression in primary cultures of human intestinal microvascular endothelial cells. cDNA array analysis revealed that sodium butyrate augmented ICAM-1 mRNA expression, while it inhibited IL-6 and COX-2 expression in response to LPS stimulation. These results were confirmed at the protein level. Prostaglandin E2 production by LPS was also strongly inhibited by butyrate. The pattern of altered gene expression by butyrate was reproduced by the histone deacetylase inhibitor tricostatin A, suggesting that the regulatory mechanism of butyrate on HIMEC gene expression involves histone deacetylase inhibition. IkappaBalpha degradation and NF-kappaB activation were unaffected by butyrate. In addition to effects on epithelium, sodium butyrate modulates the innate mucosal immune response towards LPS through effects on microvascular endothelial function. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:512 / 519
页数:8
相关论文
共 38 条
[1]   High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes [J].
Andersson, U ;
Wang, HC ;
Palmblad, K ;
Aveberger, AC ;
Bloom, O ;
Erlandsson-Harris, H ;
Janson, A ;
Kokkola, R ;
Zhang, MH ;
Yang, H ;
Tracey, KJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) :565-570
[2]  
BARNARD JA, 1993, CELL GROWTH DIFFER, V4, P495
[3]   Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease [J].
Binion, DG ;
West, GA ;
Ina, K ;
Ziats, NP ;
Emancipator, SN ;
Fiocchi, C .
GASTROENTEROLOGY, 1997, 112 (06) :1895-1907
[4]   Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: A randomised, placebo controlled trial [J].
Breuer, RI ;
Soergel, KH ;
Lashner, BA ;
Christ, ML ;
Hanauer, SB ;
Vanagunas, A ;
Harig, JM ;
Keshavarzian, A ;
Robinson, M ;
Sellin, JH ;
Weinberg, D ;
Vidican, DE ;
Flemal, KL ;
Rademaker, AW .
GUT, 1997, 40 (04) :485-491
[5]   BUTYRATE OXIDATION IS IMPAIRED IN THE COLONIC MUCOSA OF SUFFERERS OF QUIESCENT ULCERATIVE-COLITIS [J].
CHAPMAN, MAS ;
GRAHN, MF ;
BOYLE, MA ;
HUTTON, M ;
ROGERS, J ;
WILLIAMS, NS .
GUT, 1994, 35 (01) :73-76
[6]   A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammmatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate [J].
Crew, TE ;
Elder, DJE ;
Paraskeva, C .
CARCINOGENESIS, 2000, 21 (01) :69-77
[7]  
D'Argenio G, 1999, ADV EXP MED BIOL, V472, P149
[8]  
Daniel TO, 1999, CANCER RES, V59, P4574
[9]   Inhibition of histone deacetylase activity by butyrate [J].
Davie, JR .
JOURNAL OF NUTRITION, 2003, 133 (07) :2485S-2493S
[10]   Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling [J].
Deroanne, CF ;
Bonjean, K ;
Servotte, S ;
Devy, L ;
Colige, A ;
Clausse, N ;
Blacher, S ;
Verdin, E ;
Foidart, JM ;
Nusgens, BV ;
Castronovo, V .
ONCOGENE, 2002, 21 (03) :427-436